Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The ELISA is a labelled immunoassay that is believed as the gold standard for the immunoassays. This immunological test is very sensitive and it is used for detection and quantification of substances comprising of antibodies, antigens, proteins, glycoproteins along with hormones. The identification of these products are accomplished by the complexing antibodies and antigens for production of measurable results. The antibody is a type of proteins which is generated by the individual’s immune system. This proteins type has specific regions which bind to the antigens.
The Asia Pacific enzyme-linked immunosorbent assay market is witnessing tremendous growth during the forecast period of 2019 - 2028. The interactions of antigens and antibodies are utilized in the ELISA testing and it allows the identification of specific proteins antibodies and antigens. The dynamic factors such as growing application of ELISA in oncology is propelling growth of Asia Pacific enzyme-linked immunosorbent assay market. Increasing incidences of cancer is also boosting growth of Asia Pacific enzyme-linked immunosorbent assay. However, several other methods of immunological methods is hampering growth of Asia Pacific Enzyme-linked immunosorbent assay market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Enzyme-linked immunosorbent assay market. In addition, complete analysis of changes on Enzyme-linked immunosorbent assay expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19.
The Asia Pacific enzyme-linked immunosorbent assay market is segmented into the type, application, end user and country.
The Asia Pacific enzyme-linked immunosorbent assay market is comprised of various type of enzyme-linked immunosorbent assay such as sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. In which competitive ELISA is also contributing to the growth of market in 2020. The competitive ELISA is also referred as the inhibition ELISA which is a surface/plate-based assay in which the plate is coated with the capture antibodies reactive to the molecule of interest. The sample which contains the native molecule of interest and enzyme coagulated recombinant proteins which act as the competing molecules are added to the coated wells.
The Asia Pacific enzyme-linked immunosorbent assay market is comprised of various application such as vaccine development, immunology, diagnostic, toxicology, drug monitoring and pharmaceutical and transplantation. In which the toxicology is also contributing to the growth of market in 2020. The enzyme-linked immunosorbent assay screening technique is widely used by the toxicologist for the screening of forensic specimens for drug abuse. This immunoassay technique is exceptionally flexible and having high sensitivity to go down to the drug levels found in most forensic matrices.
The Asia Pacific enzyme-linked immunosorbent assay market is comprised of end user such as hospital and diagnostic centres, research laboratories and other. In which research laboratories is also contributing to the growth of market in 2020. The growing research activities in healthcare sector is propelling growth of Asia Pacific enzyme-linked immunosorbent assay market. The rising prevalence of infectious diseases is also boosting growth of Asia Pacific enzyme-linked immunosorbent assay market. The growing spending in research activities is also refuelling growth of Asia Pacific enzyme-linked immunosorbent assay market.
The Asia Pacific enzyme-linked immunosorbent assay market is studied for key countries such as China, India, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The growing healthcare expenditure is boosting growth of Asia Pacific enzyme-linked immunosorbent assay market. The rising rate of chronic diseases is propelling growth of Asia Pacific enzyme-linked immunosorbent assay market. The growing demand for early diagnosis is also driving growth of Asia Pacific enzyme-linked immunosorbent assay market.
The major key players of Enzyme-linked immunosorbent assay market are Alpco, Abcam Plc, Agilent Technologies Inc., BD Biosciences, Bio-Rad Laboratories Inc., Biolegend Inc., Enzo Life Sciences Inc., F. Hoffmann-La Roche Ltd., Merck Kgaa, Mercodia Ab, Ortho-Clinical Diagnostics Inc., Perkinelmer Inc., Qiagen Nv, R&D Systems Inc., Shenzen Yhlo Biotech Co. Ltd., Thermo Fischer Scientific Inc., Zeus Scientific, Inc. and Biomérieux Sa among others.
February 2021: The Thermo Fisher Scientific Inc., acquired the private point of care molecular diagnostic company named as Mesa Biotech.
February 2020: The Becton Dickinson and Co. reported a collaborated with Babson Diagnostic for bringing lab quality, little volume blood assortment to retail drug stores.
March 2018: BARD1 Life sciences, The U.S. based science research company is expected the commercialization of BARD1-Ovarian blood based ELSIA test for distinguishing ovarian diseases in the beginning phase.
January 2018: The Eagle Biosciences Inc., presented a novel unblemished FGF23 ELISA unit test which is the 96 well sandwich ELISA examination. It is estimated as full-length dynamic type of human Intact FGF23 utilized for the discovery of mineral bone disorder, chronic kidney disorder, chronic kidney disease and hyperphosphatemia.
The report analyses the Enzyme-linked immunosorbent assay market based on type, application, end user and country. The various type of ELISA test covered in the report are sandwich ELISA, indirect ELISA, direct ELISA and competitive ELISA. By application, the market is segmented into the vaccine development, immunology, diagnostics, toxicology, drug monitoring and pharmaceuticals and transplantation. Based on end user, the market is segmented into the hospital and diagnostic centre, research laboratories and other. The report also analyses the impact of COVID-19 on the Enzyme-linked immunosorbent assay market and it is analyses that the COVID-19 has almost affected every market is healthcare industries positively or negatively. The rising cases of COVID-19 and adoption of technically advanced test for detection of infectious diseases in patients is rising demand of Enzyme-linked immunosorbent assay. The Enzyme-linked immunosorbent assay test is more sensitive than other tests for detection of infectious disease in patients. Thereby, the Enzyme-linked immunosorbent assay market has positive impact of COVID-19. The report also covers the major key players operating in the market.
Why to buy this report
